cabergoline

Known as: cabergoline parkinsons, Cabergolina, (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide 
A synthetic ergoline derivative and a long-acting dopamine receptor agonist with high affinity for the dopamine D2 receptor. Cabergoline exerts an… (More)

Topic mentions per year

Topic mentions per year

1986-2018
05010019862018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND Cabergoline is a long-acting dopamine receptor agonist used to treat prolactinomas. Identification of D(2) receptors… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND The role of dopamine agonists in the treatment of Cushing's disease (CD) has been previously debated. AIM The aim of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Case reports and echocardiographic studies suggest that the ergot-derived dopamine agonists pergolide and cabergoline… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The authors test a neurocomputational model of dopamine function in cognition by administering to healthy participants low doses… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2002
2002
We collected information on 61 pregnancies in 50 women treated with cabergoline. These pregnancies resulted in 12 (19.7%) early… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Cabergoline is a new, long acting, dopamine agonist that is more effective and better tolerated than bromocriptine in patients… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
This multicentre randomised double-blind 3- to 5-year trial was designed to assess whether initial therapy with cabergoline alone… (More)
Is this relevant?
1996
1996
The goal of this article is to assess the reproductive safety of cabergoline, a new ergot derivative proposed in… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
BACKGROUND Cabergoline is a long-acting dopamine-agonist drug that suppresses prolactin secretion and restores gonadal function… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?